Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
Bioss COVID-19 Products
The ultimate goal of Bioss is to improve the health and quality of life of humans and animals. To fight against COVID-19, Bioss has developed antibodies, proteins, and the ELISA kit in support of studies on the novel coronavirus.
Quality Antibody Promotion
In honor of scientists who are doing fantastic research, we are presenting a collection of 45 popular featured Quality Antibodies with a 25% discount.
Pennybody Promotion
Haven't worked with Bioss Antibodies before? Try one of our 20uL trial-sized vials for just $0.01 plus shipping. Click here to view program details and to request your discount code for this promotional pricing.
Bioss Blog: the conversation with sciences
A cohort study on the long-term effectiveness of Pfizer mRNA vaccine in the USASince the delta variant of the novel coronavirus has spread in the United States, more and more breakthrough cases (still infected after vaccination) caught people's attention, and a concern that the protective effect of the new mRNA vaccine is getting weaker was raised. To address this question, we must determine whether these breakthrough infections were driven by the delta mutant strain, or were they due to the decline of immunity per se?
Biomarkers in Alzheimer’s DiseaseBiomarkers offer valuable tools to measure and track different disease mechanisms, cellular alterations, and disturbances in pathways “in vivo” and pave the way for discovering novel drug targets.
SARS-CoV-2 Variants and the Diagnostic ImmunoassayThe recent emergence of SARS-CoV-2 variants has prompted concerns as to their susceptibility to vaccine neutralization. Meanwhile, another concern on whether such strains may evade detection by diagnostics draws equal attention because this possibility will dampen our accuracy of disease tracking.
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
About Us
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.